(1 - 6 from 9
)
Amag Says Iron Replacement Therapy Results Positive
www.fdanews.com
Amag President and CEO Brian Pereira said the company wants to commercialize ferumoxytol to treat iron deficiency anemia in patients with chronic kidney disease and expects the FDA to rule on its NDA in late October.
sorted by relevance / date